Zhong Chen

4.3k citations
169 papers · 3.0k indexed · h-index 31
Topics
MicroRNA in disease regulation (17 papers)Urinary Bladder and Prostate Research (16 papers)Cancer-related molecular mechanisms research (15 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Zhong Chen

160 papers receiving 2.9k citations

Peers

Zhong Chen
Comparison fields: 5 of 135
  • Molecular Biology 1.4k
  • Cancer Research 591
  • Oncology 362
  • Pulmonary and Respiratory Medicine 348
  • Surgery 315
Replace Sandra Barth with:
Sandra Barth Germany
Xu Yao China
Paula A. Oliveira Portugal
Alice P. Pentland United States
Zhihua Chen China
Xia Chen China
Cristiana Tănase Romania
Hideaki Ito Japan
Shaopeng Yuan China
Xia Wang China
Zhong Chen relative to Sandra Barth Germany Sandra Barth's profile →
Citations per field
00.5×1.5×
Sandra Barth · 1×
Citations per year

Countries citing papers authored by Zhong Chen

Since Specialization
Citations

This map shows the geographic impact of Zhong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhong Chen more than expected).

Fields of papers citing papers by Zhong Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhong Chen. The network helps show where Zhong Chen may publish in the future.

Co-authorship network of co-authors of Zhong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Zhong Chen. A scholar is included among the top collaborators of Zhong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhong Chen. Zhong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 0
5 1
6 0
7 2
8 1
9 1
10 1
11 2
12 1
13 2
14 49
15
Effect of P120(ctn) Silence and Overexpression on Cell Migration and Invasion of Oral Squamous Cell Carcinoma
1
16 7
17 3
18 57
19 79
20 5

About Zhong Chen

Zhong Chen is a scholar working on Urology, Cancer Research and Molecular Biology, having authored 169 papers that have together received 3.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (17 papers), Urinary Bladder and Prostate Research (16 papers) and Cancer-related molecular mechanisms research (15 papers). The work is most often cited by research in Cancer Research (591 citations), Urology (141 citations) and Molecular Medicine (107 citations). Zhong Chen has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Carter Van Waes, Zhijun Han, Wei Li, Kai Cui, Zhangqun Ye, Long‐Cheng Li, Mengyang Zhang, Chenghe Wang, Elena Loukinova and Lisa Gangi. Their work appears in journals such as ACS Nano, PLoS ONE and Biomaterials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026